Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
Blood|August 9, 2012
Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cellsMin Lu, Xiaoli Wang, Yan Li, et al.
Experimental Hematology|March 23, 2010
Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathwayMin Lu, Wei Zhang, Yan Li, et al.
Cytotherapy|May 23, 2021
Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenograftsChristoph Schaniel, Luena Papa, Marcia L Meseck, et al.
Haematologica|June 3, 2016
Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategiesAbdallah Abou Zahr, Mohamed E Salama, Nicole Carreau, et al.
Scientific Reports|April 28, 2018
Survey and evaluation of mutations in the human KLF1 transcription unitMerlin Nithya Gnanapragasam, John D Crispino, Abdullah M Ali, et al.
Blood Advances|September 23, 2018
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cellsXiaoli Wang, Cing Siang Hu, Bruce Petersen, et al.
Blood Cells, Molecules & Diseases|August 22, 2008
Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disordersSelcuk Sozer, Xiaoli Wang, Wei Zhang, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 21, 2012
Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune-mediated sensorineural hearing lossMaja Svrakic, Shresh Pathak, Eliot Goldofsky, et al.
Case Reports in Hematology|February 7, 2019
The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with RuxolitinibDouglas Tremblay, Juan Putra, Alexander Vogel, et al.
British Journal of Haematology|July 14, 2026
Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathwaysTrinayan Kashyap, Andrea A Ellero, Christopher J Walker, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Blood|August 9, 2012
Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cellsMin Lu, Xiaoli Wang, Yan Li, et al.
Experimental Hematology|March 23, 2010
Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathwayMin Lu, Wei Zhang, Yan Li, et al.
Cytotherapy|May 23, 2021
Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenograftsChristoph Schaniel, Luena Papa, Marcia L Meseck, et al.
Haematologica|June 3, 2016
Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategiesAbdallah Abou Zahr, Mohamed E Salama, Nicole Carreau, et al.
Scientific Reports|April 28, 2018
Survey and evaluation of mutations in the human KLF1 transcription unitMerlin Nithya Gnanapragasam, John D Crispino, Abdullah M Ali, et al.
Blood Advances|September 23, 2018
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cellsXiaoli Wang, Cing Siang Hu, Bruce Petersen, et al.
Blood Cells, Molecules & Diseases|August 22, 2008
Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disordersSelcuk Sozer, Xiaoli Wang, Wei Zhang, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 21, 2012
Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune-mediated sensorineural hearing lossMaja Svrakic, Shresh Pathak, Eliot Goldofsky, et al.
Case Reports in Hematology|February 7, 2019
The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with RuxolitinibDouglas Tremblay, Juan Putra, Alexander Vogel, et al.
British Journal of Haematology|July 14, 2026
Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathwaysTrinayan Kashyap, Andrea A Ellero, Christopher J Walker, et al.
Pageof 21